ATE303774T1 - Vorrichtung und verfahren zur behandlung von erektionsstörungen - Google Patents

Vorrichtung und verfahren zur behandlung von erektionsstörungen

Info

Publication number: ATE303774T1
Authority: AT; Austria
Prior art keywords: treating erection; methods; disorders; erection disorders; treating
Prior art date: 1998-06-25

Application number

AT99930719T

Other languages

English (en)

Inventor

Spiros Fotinos

Original Assignee

Lavipharm Lab Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-25

Filing date

1999-06-25

Publication date

2005-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22223792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE303774(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-06-25 Application filed by Lavipharm Lab Inc filed Critical Lavipharm Lab Inc

2005-09-15 Application granted granted Critical

2005-09-15 Publication of ATE303774T1 publication Critical patent/ATE303774T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/41—Devices for promoting penis erection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Dermatology (AREA)
Nursing (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Urology & Nephrology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Attitude Control For Articles On Conveyors (AREA)

AT99930719T 1998-06-25 1999-06-25 Vorrichtung und verfahren zur behandlung von erektionsstörungen ATE303774T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9067498P	1998-06-25	1998-06-25
PCT/US1999/014410 WO1999066870A1 (en)	1998-06-25	1999-06-25	A device and method for the treatment of erectile dysfunction

Publications (1)

Publication Number	Publication Date
ATE303774T1 true ATE303774T1 (de)	2005-09-15

Family

ID=22223792

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99930719T ATE303774T1 (de)	1998-06-25	1999-06-25	Vorrichtung und verfahren zur behandlung von erektionsstörungen

Country Status (11)

Country	Link
EP (1)	EP1089679B1 (de)
JP (1)	JP2002518417A (de)
AT (1)	ATE303774T1 (de)
AU (1)	AU765057B2 (de)
CA (1)	CA2335736A1 (de)
DE (1)	DE69927154T2 (de)
HU (1)	HUP0103206A3 (de)
IL (2)	IL140475A0 (de)
NZ (1)	NZ509031A (de)
PL (1)	PL345087A1 (de)
WO (1)	WO1999066870A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6552024B1 (en) *	1999-01-21	2003-04-22	Lavipharm Laboratories Inc.	Compositions and methods for mucosal delivery
EP1200064B1 (de)	1999-07-02	2003-05-02	The Procter & Gamble Company	Zusammensetzungen zur freisetzung von mundpflegewirkstoffen enthaltend organosiloxan harze durch verwendung eines wiederablösbaren trägerstreifens
KR100402334B1 (ko)	2000-06-23	2003-10-22	환인제약 주식회사	알프로스타딜 외용제
NZ524601A (en) *	2000-08-30	2006-04-28	Unimed Pharmaceuticals Inc	Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en)	2000-08-30	2003-01-07	Unimed Pharmaceuticals, Inc.	Pharmaceutical composition and method for treating hypogonadism
US6899897B2 (en) *	2001-06-18	2005-05-31	Jaleva, Inc.	Gum resin as a carrier for topical application of pharmacologically active agents
US8524200B2 (en)	2002-09-11	2013-09-03	The Procter & Gamble Company	Tooth whitening products
US20050181030A1 (en) *	2003-01-03	2005-08-18	Mo Y. J.	Topical stabilized prostaglandin E compound dosage forms
US6841574B2 (en) *	2003-01-03	2005-01-11	Nexmed Holdings, Inc.	Topical stabilized prostaglandin E compound dosage forms
ME00479B (me)	2003-01-31	2011-10-10	Daiichi Sankyo Co Ltd	Lijek za profilaksu i tretman arterioskleroze i hipertenzije
CN1787824A (zh) *	2003-06-25	2006-06-14	有限会社循环器研究所	性交功能改善用外用制剂
US9554984B2 (en)	2003-11-03	2017-01-31	Jaleva Pharmaceuticals, Llc	Oral care compositions for topical application
CA2629810A1 (en)	2005-11-07	2007-05-18	Jaleva, Llc	Film-forming resins as a carrier for topical application of pharmacologically active agents
IT201600119871A1 (it) *	2016-11-25	2018-05-25	Sabatino Russo	Uso dell’associazione di inibitori della fosfodiesterasi 5 con prostaglandina e1 per il trattamento della disfunzione erettile

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4725439A (en) *	1984-06-29	1988-02-16	Alza Corporation	Transdermal drug delivery device
JPS61204117A (ja) *	1985-03-07	1986-09-10	Tooa Eiyoo Kk	経皮吸収外用剤
FI872552L (fi)	1986-06-09	1987-12-10	American Cyanamid Co	Prostaglandinkomposition foer lokalt bruk.
EP0266968A3 (de) *	1986-11-03	1988-08-24	Gérard G. Cohen	Gelierte Salbe mit einem Vasodilator
US4829991A (en) *	1987-01-06	1989-05-16	Medical Engineering Corp.	Method and device for stimulating an erection
SU1705319A1 (ru) *	1987-10-23	1992-01-15	Всесоюзный Научно-Исследовательский Институт Биотехнологии	Состав полимерной диффузионной матрицы дл трансдермального введени лекарственных веществ
US5242391A (en)	1990-04-25	1993-09-07	Alza Corporation	Urethral insert for treatment of erectile dysfunction
IT1247678B (it)	1990-05-31	1994-12-28	Alberto Reale	Metodo per la cura dell'impotenza erettiva maschile
US5202125A (en) *	1990-12-10	1993-04-13	Theratech, Inc.	Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
DE4117249C2 (de)	1991-05-27	1998-05-14	Christian Dr Stief	Linsidomin zur Behandlung erektiler Dysfunktionen
ES2136093T3 (es) *	1991-11-11	1999-11-16	Hisamitsu Pharmaceutical Co	Fomentacion que contiene cetorolac.
KR950701516A (ko) *	1992-05-13	1995-04-28	에드워드 엘. 만델	옥시부티닌의 경피 투여(Transdermal Administration of Oxybutynin)
US5333621A (en) *	1993-05-28	1994-08-02	Eric Denzer	Condom with transdermal vasodilator
CA2161974A1 (en) *	1993-05-28	1994-12-08	Eric L. Denzer	Condom with transdermal vasodilator
US6007836A (en) *	1993-05-28	1999-12-28	Vericade, Inc.	Transdermal vasodilator
GB9311920D0 (en)	1993-06-09	1993-07-28	Pfizer Ltd	Therapeutic agents
ES2180658T3 (es) *	1994-11-17	2003-02-16	Toray Industries	Preparado para absorcion percutanea.
FR2729296B1 (fr) *	1995-01-12	1997-03-28	Europlanaire	Compositions pharmaceutiques comprenant une superoxyde dismutase
US5741511A (en) *	1995-04-12	1998-04-21	Sam Yang Co., Ltd.	Transdermal drug delivery device for treating erectile dysfunction
FR2748658B1 (fr) *	1996-05-15	2000-08-18	Biotec Centre Sa	Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique
ES2191834T3 (es) *	1996-10-24	2003-09-16	Alza Corp	Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.

1999
- 1999-06-25 IL IL14047599A patent/IL140475A0/xx active IP Right Grant
- 1999-06-25 AT AT99930719T patent/ATE303774T1/de not_active IP Right Cessation
- 1999-06-25 NZ NZ509031A patent/NZ509031A/xx unknown
- 1999-06-25 PL PL99345087A patent/PL345087A1/xx unknown
- 1999-06-25 DE DE69927154T patent/DE69927154T2/de not_active Revoked
- 1999-06-25 EP EP99930719A patent/EP1089679B1/de not_active Revoked
- 1999-06-25 HU HU0103206A patent/HUP0103206A3/hu unknown
- 1999-06-25 CA CA002335736A patent/CA2335736A1/en not_active Abandoned
- 1999-06-25 JP JP2000555558A patent/JP2002518417A/ja active Pending
- 1999-06-25 WO PCT/US1999/014410 patent/WO1999066870A1/en active IP Right Grant
- 1999-06-25 AU AU47200/99A patent/AU765057B2/en not_active Ceased
2000
- 2000-12-21 IL IL140475A patent/IL140475A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL140475A (en)	2007-05-15
AU4720099A (en)	2000-01-10
WO1999066870A1 (en)	1999-12-29
PL345087A1 (en)	2001-12-03
NZ509031A (en)	2002-10-25
EP1089679A1 (de)	2001-04-11
EP1089679B1 (de)	2005-09-07
IL140475A0 (en)	2002-02-10
AU765057B2 (en)	2003-09-04
DE69927154D1 (de)	2005-10-13
JP2002518417A (ja)	2002-06-25
CA2335736A1 (en)	1999-12-29
HUP0103206A3 (en)	2002-11-28
DE69927154T2 (de)	2006-06-29
HUP0103206A2 (hu)	2002-05-29

Publication	Publication Date	Title
ATE303774T1 (de)	2005-09-15	Vorrichtung und verfahren zur behandlung von erektionsstörungen
DE60011918D1 (de)	2004-08-05	Vorrichtung und verfahren zur lokalen behandlung von wasser
DE69829336D1 (de)	2005-04-21	Vorrichtung und Verfahren zur Behandlung von Körpergewebe
DE69829625D1 (de)	2005-05-12	Verfahren und Vorrichtung zur Behandlung von Perfluorokohlenstoff
DE69807538D1 (de)	2002-10-10	Vorrichtung und Verfahren zur Behandlung von Gewebe
DE69732152D1 (de)	2005-02-03	Vorrichtung zur Behandlung von Kopfschmerzen
DE69829921D1 (de)	2005-06-02	Vorrichtung zur Behandlung von Körpergewebe
TR199901669T2 (xx)	2000-07-21	Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
DE69730097D1 (de)	2004-09-09	Verfahren und Vorrichtung zur Behandlung von Wafers
WO2002041837A3 (en)	2003-03-06	Treatment of mucositis
DE60032795D1 (de)	2007-02-15	Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69939058D1 (de)	2008-08-21	Vorrichtung zur behandlung von peripheren gefässerkrankungen
DE69112480D1 (de)	1995-10-05	Verfahren und Vorrichtung zur Behandlung von medizinischen Abfallstoffen.
DE69732452D1 (de)	2005-03-17	Verfahren und Vorrichtung zur Einleitung von Funknachrichten
ATE335503T1 (de)	2006-09-15	Methoden und geräte zur applikation von substanzen in brustmilchgänge
DE69925266D1 (de)	2005-06-16	Verfahren und gerät zur behandlung von herzarhythmie
DE60038561D1 (de)	2008-05-21	Granulationsvorrichtung mit zentrifugalrollen und verfahren zur behandlung von puder und granularem material mit dieser vorrichtung
ATE292454T1 (de)	2005-04-15	Vorrichtung und verfahren zur wundbehandlung
DE69918306T2 (de)	2004-10-21	Verfahren und vorrichtung zur behandlung von arrythmien
DE3784753D1 (de)	1993-04-22	Vorrichtung und verfahren zur behandlung stehender gewaesser.
DE69942742D1 (de)	2010-10-21	Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs
DE50213931D1 (de)	2009-11-26	Verfahren und vorrichtung zur behandlung von fehlerverdacht
DE60128427D1 (de)	2007-06-28	Verfahren und Einrichtungen zur elekrochemischen Behandlung eines Artikels
ATE283920T1 (de)	2004-12-15	Verfahren zur immunisierung und behandlung von h. pylori infektion
DE60144493D1 (de)	2011-06-01	Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen

Legal Events

Date	Code	Title	Description
2006-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties